Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
McVie-Veronesi Awards: 2nd prize - Harnessing artificial intelligence to mitigate depression rates in cancer clinicians
McVie-Veronesi awards: Exploring the physical symptom burden in actively dying cancer patients.
McVie-Veronesi Awards:Harnessing machine learning to create predictive models in mitigating disease states
McVie-Veronesi Awards: 3rd Prize - Role of sentinel lymph node biopsy in node positive breast cancer patients? Converting to node negativity after neoadjuvant chemotherapy
McVie-Veronesi Awards: Molecular detection of circulating types of human papillomavirus infection in West Bengal
McVie-Veronesi awards: Case reports on struma ovarii
McVie-Veronesi awards: 1st Prize - Insights into journeys of cancer patients in India - Access, affordability and barriers
Myeloma treatment and prognosis
Interpreting the results of a clinical trial
Writing IMRAD introduction, methods, results, discussion
Breast cancer screening global approaches